NASDAQ · XLO
Xilio Therapeutics, Inc.
Healthcare · Biotechnology
$8.08
Down-$0.38 (-4.64%)
Updated Nov 17, 2026, 1:36 AM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 37.56M
- P/E ratio
- -2.44
- Dividend yield
- 0.00%
- 52-week range
- $6.47 – $11.30
- Volume
- 7.58K
- Avg. volume
- 620.67K
Price performance · XLO
XLO price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
XLO closed at $8.08 after 20 trading sessions, down 3.06% for the selected period.
- Last close
- $8.08
- Period change
- -3.06%
- Period low
- $7.31
- Period high
- $9.00
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $7.96 | $8.075 | $7.60 | $8.075 | 7.58K |
| Nov 12, 2026 | $8.25 | $8.25 | $7.96 | $8.24 | 9.09K |
| Nov 11, 2026 | $8.82 | $8.85 | $8.40 | $8.47 | 3.53K |
| Nov 10, 2026 | $8.82 | $8.82 | $8.53 | $8.53 | 3.08K |
| Nov 9, 2026 | $8.8567 | $9.00 | $8.57 | $9.00 | 10.72K |
| Nov 6, 2026 | $8.24 | $8.69 | $8.24 | $8.62 | 6.78K |
| Nov 5, 2026 | $8.45 | $8.65 | $7.775 | $8.50 | 27.23K |
| Nov 4, 2026 | $8.425 | $8.86 | $8.425 | $8.71 | 11.79K |
| Nov 3, 2026 | $8.03 | $8.85 | $7.935 | $8.68 | 24.49K |
| Nov 2, 2026 | $7.49 | $8.065 | $7.49 | $7.99 | 6.84K |
| Oct 30, 2026 | $7.0501 | $8.0889 | $7.0501 | $8.03 | 7.91K |
| Oct 29, 2026 | $8.20 | $8.20 | $7.77 | $7.77 | 2.71K |
| Oct 28, 2026 | $7.81 | $8.19 | $7.57 | $8.01 | 16.68K |
| Oct 27, 2026 | $7.855 | $8.09 | $7.17 | $8.01 | 27.93K |
| Oct 26, 2026 | $7.54 | $8.6368 | $7.05 | $7.31 | 33.45K |
| Oct 23, 2026 | $8.06 | $8.245 | $7.51 | $7.57 | 16.25K |
| Oct 22, 2026 | $8.45 | $8.48 | $8.00 | $8.03 | 15.37K |
| Oct 21, 2026 | $8.545 | $9.05 | $8.2487 | $8.43 | 36.27K |
| Oct 20, 2026 | $8.25 | $8.84 | $8.25 | $8.54 | 13.51K |
| Oct 19, 2026 | $8.69 | $8.735 | $8.33 | $8.33 | 11.49K |
Latest XLO news
The latest Smart Investors Daily articles mentioning XLO.
Stock researchResearch & News · News
Company
Market Activity
Research & News

